PointofLaw.com

spacer FORUM FEATURED DISCUSSIONS PoL COLUMNS LEGAL EXPERTS ARTICLES BOOKS LINKS MASTHEAD ADVANCED SEARCH

FORUM

« The U.S. Navy and the asbestos calamity | Stoneridge: "Just Say 'No' to the Trial Lawyers" »

October 9, 2007


Arkansas drug suit, cont'd

The Chamber's Southeast Texas Record reports that Arkansas AG Dustin McDaniel has hired Houston-based Bailey Perrin Bailey on a 15 percent contingency to go after AstraZeneca, Eli Lilly and Johnson & Johnson, the makers of Seroquel, Zyprexa and Risperdal respectively, for Medicaid damages arising from alleged mismarketing. The hoped-for damages apparently reach $600 million, though that would seem to assume that all sales of the (powerful and highly useful) psychiatric drugs to state purchasers were illegitimate. Earlier: Oct. 4.

Posted by Walter Olson at 12:11 AM | TrackBack (0)



categories:
Regulation Through Litigation









 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.